DIL
ROIV icon

Deeter Investments LLP’s Roivant Sciences ROIV Stock Holding History

Deeter Investments LLP’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.23M Buy
+56,485
New +$1.11M 0.26% 54

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deeter Investments LLP's ROIV Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in Roivant Sciences (ROIV) in Q4 2025: 56,485 shares worth $1.23M. The stake represents 0.26% of the portfolio and ranks #54 among its holdings.

400 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Deeter Investments LLP held 56,485 shares of Roivant Sciences worth $1.23M as of Q4 2025.
  • Roivant Sciences was a new Deeter Investments LLP position in Q4 2025.
  • Roivant Sciences made up 0.26% of Deeter Investments LLP's portfolio in Q4 2025, its #54 holding.
  • 400 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.